A comparison of anti-CD20 chimeric antigen receptors in targeting B-cell malignancies

被引：0
|
作者：
Britton, R. [1 ]
French, R. [1 ]
Glennie, M. [1 ]
机构：
[1] Univ Southampton, Southampton, Hants, England
来源：
IMMUNOLOGY | 2013年 / 140卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：65 / 65
页数：1
相关论文
共 50 条
  • [1] Generation and comparison of anti-CD20 chimeric antigen receptors with target B-cell malignancies
    Britton, R. H.
    French, R. R.
    Chan, C. H. T.
    Cragg, M. S.
    Glennie, M. J.
    [J]. IMMUNOLOGY, 2014, 143 : 129 - 129
  • [2] Development of Anti-CD20 Antigen-Targeting Therapies for B-cell Lymphoproliferative Malignancies - The State of the Art
    Witkowska, Magdalena
    Smolewski, Piotr
    [J]. CURRENT DRUG TARGETS, 2016, 17 (09) : 1072 - 1082
  • [3] Ofatumumab, a Novel Anti-CD20 Monoclonal Antibody for the Treatment of B-Cell Malignancies
    Cheson, Bruce D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (21) : 3525 - 3530
  • [4] T Cells Expressing Anti B-Cell Maturation Antigen Chimeric Antigen Receptors for Plasma Cell Malignancies
    Li, Chunrui
    Wang, Qiuxiang
    Zhu, Hui
    Mao, Xia
    Wang, Ying
    Zhang, Yicheng
    Zhou, Jianfeng
    [J]. BLOOD, 2018, 132
  • [5] New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies
    Robak, Tadeusz
    Robak, Ewa
    [J]. BIODRUGS, 2011, 25 (01) : 13 - 25
  • [6] New Anti-CD20 Monoclonal Antibodies for the Treatment of B-Cell Lymphoid Malignancies
    Tadeusz Robak
    Ewa Robak
    [J]. BioDrugs, 2011, 25 : 13 - 25
  • [7] Anti-CD22-chimeric antigen receptors targeting B-cell precursor acute lymphoblastic leukemia
    Haso, Waleed
    Lee, Daniel W.
    Shah, Nirali N.
    Stetler-Stevenson, Maryalice
    Yuan, Constance M.
    Pastan, Ira H.
    Dimitrov, Dimiter S.
    Morgan, Richard A.
    FitzGerald, David J.
    Barrett, David M.
    Wayne, Alan S.
    Mackall, Crystal L.
    Orentas, Rimas J.
    [J]. BLOOD, 2013, 121 (07) : 1165 - 1174
  • [8] Anti-CD20 treatment for B-cell malignancies: current status and future directions
    Klein, Christian
    Jamois, Candice
    Nielsen, Tina
    [J]. EXPERT OPINION ON BIOLOGICAL THERAPY, 2021, 21 (02) : 161 - 181
  • [9] Stromal cell inhibition of anti-CD20 antibody mediated killing of B-cell malignancies
    Fagnano, Ester
    Pendharkar, Swati
    Colton, Madyson
    Jones, Philip N.
    Sallan, Marta Crespi
    Klymenko, Tetyana
    Braun, Andrejs
    Klein, Christian
    Honeychurch, Jamie
    Cheadle, Eleanor J.
    Illidge, Timothy M.
    [J]. FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [10] An anti-CD20 extracellular antibody-drug conjugate for the treatment of B-cell malignancies
    Prudent, James R.
    Hall, Chad A.
    Marshall, David J.
    Murphy, John
    Harried, Scott
    [J]. CANCER RESEARCH, 2016, 76
12345